fate stock price target

FATEs pricesales ratio is 7242. Stock Price Forecast The 20 analysts offering 12-month price forecasts for Fate Therapeutics Inc have a median target of 8200 with a high estimate of 13500 and a low estimate of 2800.

Fate Stock Price And Chart Nasdaq Fate Tradingview

And has now gained 4 days in a rowIt will be exciting to see whether it manages to continue gaining or take a minor break for the next few days.

. FATE stock price quote with breaking news financials statistics charts and more. Their FATE stock forecasts range from 2800 to 11600. The current analyst and expert consensus on Fate Therapeutics is Buy with 4 hold recommendations.

49 rows FATE Stock Trend. The companys stock has been forecasted to trade at an average price of 8150 over the course of the next 52 weeks with a low of 2800 and a high of 13500. Of note is the ratio of Fate Therapeutics Incs sales and general administrative expense to its total operating expenses.

The Fate Therapeutics stock price gained 621 on the last trading day Wednesday 22nd Jun 2022 rising from 2223 to 2361. Based on analysts offering 12 month price targets for FATE in the last 3 months. 31 minutes agoThey set a neutral rating and a 2800 target price on the stock.

Analyst ratings historical stock prices earnings estimates actuals. 21682 Upside Based on 9 Wall Street analysts offering 12 month price targets for Fate Therapeutics in the last 3 months. The 3 Wall Street analysts offering Fate Therapeutics stock forecast in the last 6 months have average price target of 860 with a high forecast of 1220 and a low forecast of 620.

HC Wainwright cut their price target on shares of Fate Therapeutics from 12200 to 11500 and set a buy rating on the stock in a report on Friday March 4th. The average price target represents a 21682 change from the last price of 2223. The average price target is 000 with a high estimate of 000 and a low estimate of 000.

Analyst Price Target on FATE. 11 brokers have issued 12-month target prices for Fate Therapeutics shares. According to the issued ratings of 11 analysts in the last year the consensus rating for Fate Therapeutics stock is Moderate Buy based on the current 3 hold ratings and 8 buy ratings for FATE.

Get a real-time Fate Therapeutics Inc. One of the most common ways Fate Therapeutics analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial. Fate Therapeutics stock price target raised to 79 from 58 at Stifel Nicolaus Dec.

The current projected Fate Therapeutics target price consensus is 1072 with 15 analyst opinions. View FATE revenue estimates and earnings estimates as well as in-depth analyst breakdowns. During the day the stock fluctuated 1207 from a day low at 2137 to a day.

ET by Tomi Kilgore Fate Therapeutics stock price target raised to 88 from 55 at Wedbush. Given the current short-term trend the stock is expected to fall -4510 during the next 3 months and with a 90 probability hold a price between 453 and 1431 at the end of this 3-month period. Based on these price targets the low is -933 off current price whereas the price has to move -42714 to reach the yearly target high.

Ad Diversify your portfolio with guidance from investment professionals. The average twelve-month price prediction for Fate Therapeutics is 8036 with a high price target of 11600 and a low price target of 2800. On average they expect Fate Therapeutics stock price to reach 8036 in the next twelve months.

The huge jump came after the biotech announced positive interim data from an. FATE updated stock price target summary. Positive dynamics for Fate Therapeutics shares.

Stock Price Target FATE. Analyst Price Targets 19 Current 2075. 8313 2951 Earnings Date.

Stock Price Forecast According to 26 stock analysts the average 12-month stock price forecast for FATE stock is 8313 which predicts an increase of 36755. Get the latest Fate Therapeutics stock price and detailed information including FATE news historical charts and realtime prices. 1y Target Est 8150 Fair Value is the appropriate price for the shares of a company based on its earnings and growth rate also interpreted as when PE Ratio Growth Rate.

What happenedShares of Fate Therapeutics NASDAQ. According to 7 Wall Street analyst s that have issued a 1 year FATE price target the average FATE price target is 7643 with the highest FATE stock price forecast at 11500 and the lowest FATE stock price forecast at 2800. This suggests a possible upside of 2138 from the stocks current price.

FATE stock price quote with breaking news financials statistics charts and more. The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Research and ratings by Barrons.

The average price target is 7043 with a high forecast of 11500 and a low forecast of 2800. Fate Therapeutics Stock Forecast 06-17-2022. Finally HC Wainwright cut their price target on Fate Therapeutics from 12200 to.

Forecast target price for 06-17-2022. Get a real-time Fate Therapeutics Inc. Heres where we think you should invest.

Extra money in your bank account. Merely 827 of US stocks have a lower such ratio. Do note that if the.

The average Fate Therapeutics stock forecast represents a 12228 increase from the last price of 38689998626709. Learn more on FATEs analyst rating. The lowest target is 2828 and the highest is 14175.

FATE were skyrocketing 473 higher as of 1143 am. On average analysts rate FATE stock as a buy. 7 2020 at 750 am.

Roku Stock Forecast Streaming Pioneer Outlines Its Vision

How To Trade Stocks That Hit All Time Highs

Stock Market Today Stocks Snooze While Investors Await Inflation Update Kiplinger

Fate Stock Price And Chart Nasdaq Fate Tradingview

How To Trade Stocks That Hit All Time Highs

Ultimate Price Magic The Gathering Cards Magic The Gathering Magic Cards

Apple S Stock May Rise 8 On Strong Growth

Bidness Sheds Light On Stifel S Decision To Initiate Coverage On Solarcity Corp Nasdaq Scty Stock With A Buy Rating An Hot Tub Cover Business Finance Company